Therefore, Gal3 is overexpressed in PDA and mainly secreted by tumor cells, promoting tumor progression by autocrine direct effects on tumor cell proliferation, invasion, and migration as well as paracrine effects in the stroma by promoting activation of PSCs and negative modulation of anti-tumor immune response. This evidence concerns the gene LGALS3 and Patent ductus arteriosus.